Biotech | May 27, 2022
Lancet publishes results of Phase 3 programmes of Rinvoq in Ulcerative Colitis
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
The icare4u program features a dedicated website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers on Facebook and YouTube
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
It is a novel oral NLRP3 inflammasome inhibitor
The NFI is published to promote the rational use of medicines in the country.
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
Subscribe To Our Newsletter & Stay Updated
